FTI Consulting, Inc. FCN recently announced the appointment of Brian Flynn as a Senior Managing Director for Health Solutions practice within the Forensic and Litigation Consulting segment.
Flynn has 25 years of experience in the healthcare space. He is rejoining FTI Consulting from his own company, T2A Health Solutions LLC. He has also served as a partner in EY and as Corporate Vice President of Revenue Cycle Operations at Continuum Health Partners.
According to Charles Overstreet, Global Leader of the Health Solutions practice at FTI Consulting, “He will be a key member of the team focused on operational excellence and performance improvement, working with FTI Consulting experts across the globe to provide business transformation services to our healthcare clients.”
Shares of the company have fared well in a year’s time. The stock has gained 56.3% against the industry’s decline of 4.3%.
The new appointment comes on the heels of FTI Consulting’s recent appointment of financial investigative and litigation expert David Williams as a managing director in the Global Risk & Investigations Practice (“GRIP”) within the Forensic & Litigation Consulting segment.
The company has also appointed two securities industry veterans — Christopher Chatfield and Anthony Italiano — as senior managing directors in the Forensic Accounting & Advisory Services practice within the segment.
Boosting the Forensic & Litigation Consulting segment through these appointments appears to be part of FTI Consulting’s efforts to enhance its employees skill set and improve offerings.
Zacks Rank & Stocks to Consider
Currently, FTI Consulting carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
A few better-ranked stocks in the Zacks Business Services sector are General Finance Corp. GFN, Information Services Group, Inc. III and Paychex, Inc. PAYX, each carrying a Zacks Rank #2 (Buy).
The long-term expected EPS (three to five years) growth rate for General Finance, Information Services and Paychex is 11%, 14%, and 8.8%, respectively.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Zacks Investment Research